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Thirty publications on the effectiveness of prophylactic antiepileptic drugs (AEDs) with supratentorial craniot- 
omies were reviewed (1980-1995). After a first selection, six controlled studies remained (11 publications). These 
six were evaluated according to previously defined methodological criteria. The criteria were divided into three 
main categories: (1) internal validity, (2) proper and relevant outcome-measures and (3) analysis. In this way a 
maximum of 145 points could be obtained for each study. Three studies were considered to be of satisfactory 
methodological quality (~55% of 145 points) and the odds ratios were calculated as a measure of association 
between treatment and occurrence of convulsions. The odds ratios of these three studies were statistically pooled 
using the Mantel-Haenszel Estimator. From this test it appeared that prophylactically used AEDs showed a 
tendency to prevent postoperative convulsions, but this effect was certainly not statistically significant (P = 0.1 
one-tailed). Points of attention concerning possible future investigations are stressed. 
Key words: epilepsy prophylaxis: meta-analysis: postoperative seizure: seizure prophylaxis: supratentorial 
craniotomy. 
INTRODUCTION 
For years there has been uncertainty and a 
debate, especially between neurosurgeons and 
neurologists, about the usefulness of antiepileptic 
drugs (AEDs) prophylactically, to prevent post- 
operative convulsions after supratentorial intrac- 
ranial surgery. Many neurosurgeons prefer the 
use of prophylactic AEDs because surgical results 
can be severely compromised by postoperative 
epileptic seizures’. In the early postoperative 
period cerebral oedema, due to surgical 
manipulation, may contribute to increased in- 
tracranial pressure. A seizure causes cerebral 
hypoxia and acidosis and may lead to a further 
elevation of the intracranial pressure, hereby 
altering the level of consciousness of the patient 
and making postoperative clinical evaluation 
dificult. Intra-cerebral haemorrhages can be 
masked and may lead to catastrophic events. 
Additionally cerebral hypoxia in the course of a 
disease process constitutes a severe hazard to the 
patient , 2.3 Another argument to prevent post- 
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operative epileptic seizures (PES) is that they 
may possibly lead to secondary epileptogenic foci 
(kindling), however this is shown in animal 
studies and scientijic research has stil not shown 
that it is applicable to the human brain4,‘. On the 
other hand, many neurologists argue that a single 
epileptic convulsion, even if it is postoperative, 
does not justify the diagnosis of epilepsy, or 
long-term prophylactic treatment. Furthermore, 
the adverse effects of the AEDs (rash, gin- 
givahyperplasia, coarsening of the skin) could 
well surpass possible advantages of treatment. 
Until recently, clinical review articles concern- 
ing the prophylactic use of AEDs often relied on 
the authors’ subjective selection and interpreta- 
tion as well as the use of unpublished information 
related to the clinical topic. In most publications 
no explicit criteria were used, leaving any derived 
recommendations open to bias and error6. There- 
fore at this moment an increasing amount of 
review articles and meta-analyses are charac- 
terized by more explicit and quantitative methods 
of synthesizing data. Meta-analyses of ran- 
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domized controlled trials have been helpful not 
only to answer particular research questions, but 
also in the formulation of practical guidelines, for 
planning further clinical trials, and as a means of 
providing data required for the performance of 
decision analyses and cost-effectiveness analyse@. 
We analysed and evaluated the methodological 
quality of the studies as it was presented in the 
publication(s) on the effectiveness of prophylactic 
AEDs. Previously defined criteria were used in 
the assessment, a process which is commonly 
referred to as ‘criteria-based meta-analysis’6.7. 
Selected studies of sufficient methodological 
quality were statistically pooled. By means of this 
procedure it is attempted to obtain an overall 
conclusion concerning the effectiveness of 
prophylactic AEDs with intracranial supraten- 
torial surgery. 
METHODS AND MATERIALS 
Literature-search strategy 
First, a MEDLINE computersearchX was per- 
formed using the keywords: preoperative, anti- 
convulsants, prophylactic, phenytoin, phenobar- 
bital, carbamazepine, postoperative, epilepsy, 
craniotomy. With the help of a CD-ROMsystem 
all publications between January 1980 and Nov- 
ember 1995 that contained one, or a combination 
of more keywords, were located. Second, the 
same strategy was applied to the Excerpta Medica 
(1984-1995). Finally, the reference-listings of the 
publications were scanned for further eligible 
publications from the same period. 
Literature selection 
Publications were eligible to be included in the 
criteria-based meta-analysis if the publication 
reported a clinical trial and index, and control 
groups were used (reviews and editorials were 
ruled out). The patient-population in the trial had 
to undergo a supratentorial craniotomy for either 
therapeutic or diagnostic reasons. Head trauma in 
itself is a well recognized cause of epilepsy and 
although the underlying mechanisms that causing 
epilepsy appear to be similar to those of PES, 
including patients with head trauma could pos- 
sibly bias trial outcome. For much the same 
reason, publications which included patients with 
preoperative epileptic seizures were not selected 
(if there was a part of the patient-population in 
the trial that had had preoperative convulsions 
and/or intracranial surgery because of a neuro- 
trauma, but which was easily separable from the 
part that did not, then that study was considered 
to be eligible for further analysis in the criteria- 
based meta-analysis). 
AEDs used in the trial consisted of one, or a 
combination of the following: phenytoin, car- 
bamazepine, barbiturates. The time of ad- 
ministration of the AED-prophylaxis was within 
one week prior to surgery until one day after 
surgery. The language of the publication was 
either English, German, French, or Dutch. 
Scoring of quality 
The weight of each criterion is expressed by a 
maximum number of points and depends on the 
issue of the meta-analysis. The total score for all 
22 criteria consisted of a maximum of 145 points 
(Table 1). For each criterion a certain number of 
points could be obtained, depending on the 
extent to which its requirements were met. The 
total score of the study was expressed as a 
percentage of the maximum of 145 points. The 
percentage was used as an indication of the 
methodological quality of the trial presented in a 
publication. 
The number and the way in which points were 
assigned to the different criteria reflects the ideas 
of the authors of this review-article. Therefore, 
the data are presented in such a way that the 
reader is able to verify the scores and reset them 
to his/her own opinion. Table 1 lists all the 
criteria that were used in the meta-analysis with 
their maximum scores. Particular criteria which 
are divided in subcriteria are explained below the 
table. Arbitrarily a score of 55% was decided to 
be the cutoff point for good methodological 
quality. 
In our overall judgement of the effectiveness of 
AEDs in the prevention of epileptic seizures after 
supratentorial craniotomies, we only used results 
from trials of studies that obtained at least 80 
points (55% of 145). 
Statistical analysis 
As the general effect-parameter for all studies 
the odds ratio (OR) was used. The odds ratio 
represents the association between treatment and 
the occurrence of postoperative seizures. If the 
odds ratio equals 1, then the effect of treatment 
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Table 1: Criteria, with different weight-factors, used for scoring the methodological quality of a study 
Criteria Weighting 
Internal validity 
Comparability of prognosis 
Homogeneity (1) 
Prestratification (2) 
Randomization 
Randomization procedure described 
Comparability of relevant baseline characteristics shown (3) 
Number of patients per group (4) 
Percentages of patients lost to follow-up (5) 
Intervention and external variables 
Plasma-levels of anti-epileptics adequate (6) 
Dose anti-epileptics adequate (7) 
Compliance (8) 
Intervention procedures adequately described (9) 
10 
3 
10 
3 
5 
3/5/l 
417 
15 
3 
4 
10 . 
Effect meawrement 
Patients blinded (10) 
Evaluator blinded 
Check-up blinding 
10 
5 
2 
Proper and relevant outcome-measures 
Remark on side effects (11) 
Remark on difference of seizure-frequency between groups 
Remark on type of postoperative convulsions 
Follow-up in months after treatment (12) 
Analysis 
Data presentation (13) 
Intention-to-treat analysis 
Description of methods of analysis 
Influence of confounding variables minimized (multi-variate analysis) 
7 
10 
5 
31719 
5 
5 
5 
5 
If a publication fulfilled all criteria completely a total score of 145 points could be reached. 
(1) Pathology of the patient is in this meta-analysis considered as the most important prognostic factor, 
if the groups were comparable on this item 5 points were given. If other important prognostic variables 
were mentioned(operation-time, age of patient, manipulation of the brain. side of laesion. systemic 
diseases associated with high risk of seizures) extra points were given to a max. of 5. (2) If 
prestratification is mentioned or if the item ‘homogeneity’ scores higher than 5, three points are given. If 
the groups contain less than 50 patients each and there is no prestratification. 3 points are subtracted. 
(3) 5 points if characteristics are arranged in the form of a table. 3 points if characteristic were only 
mentioned in the text. (4) 550 patients per group: 3 points, 51-100 patients: 5 points, >lOO patients: 7 
points. (5) ~10% loss to follow-up: 7 points, ll%-20%: 4 points, >20%: 0 points. (6) If 100% of the 
patients in the intervention-group have therapeutic plasma-levels 15 points are given, e.g. 66% of the 
patients have therapeutic levels, 66% of 15 points is 10 (10 points were given). (7) 3 points if minimal 
dose agrees with Sonnen’s (9) recommendation. (8) 2 points if compliance was mentioned in patient 
number or in proportion. An extra of 2 points is given if the reason of non-compliance was mentioned. 
(9) For each of the following items 1 point can be scored: generic name of anti-epileptic medication, 
duration of intervention, method of administration of anti-epileptics, dose and number of 
administration per day. The following items are scored in a different way; plasma-levels controlled 2 
points. if not mentioned -2 points: frequency/interval of plasma-level assessment, 2 points; therapeutic 
range mentioned 2 points, if not -2. On this methodological item a maximum score of 10 points can be 
reached. (10) To a maximum of 3 points was given depending on the description of similarity between 
the placebo and the intervention-medication. (11) The max. of 7 points are divided in; 3 points for 
summing-up the side-effects, and 4 points for the number of patients having these side-effects. (12) 53 
months: 3 points. >3 months: 7 points, ~12 months: 9 points. (13) Between 3 and 5 points are given 
dependent on the comprehensiveness of data presentation. 
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vs. the effect of no treatment shows no difference 
at all in respect to prevention of postoperative 
seizures. If the effect of treatment is superior to 
no treatment, the odds ratio will be below one 
(e.g. OR = 0.5 indicates a reduction of about 
50%). On the other hand, an odds ratio above 1 
indicates that the placebo-treatment is more 
effective than prophylactic AED-treatment. 
To pool the odds ratios of the different trials 
the Mantel-Haenszel Estimator”’ was used and 
95%-confidence-intervals and the P-value were 
determined (see Fig. 1). 
RESULTS 
A total of 30 publications was found using the 
CD-ROM Medline and Excerpta Medica. Three 
Japanese publications’.“.” were excluded. Fran- 
ceschetti et al published their trial in Italian” as 
well as in English14, only the latter publication 
was used. The 30 publications consisted of 18 
studies about the effectiveness of AED- 
prophylaxis, four editorials’5-‘x, one review- 
article’, five studies’**‘“-** mainly concerning the 
incidence of postoperative epilepsy and two 
studies’.*’ regarding optimal prophylactic AED- 
regimes. In these latter two, conclusions were 
drawn concerning the effectiveness of prophylac- 
tically used AEDs, although neither one of them 
used control-groups. In five of the 18 publica- 
tions, about the effectiveness of AED- 
prophylaxis, no control-group was used”.2J-27. 
The remaining group of 13 publications was 
further reduced to eight because some studies 
were published more than once2N-30. 
Three’.‘.” of the seven studies included pati- 
ents with neurotrauma. The studies of North ef 
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al” and Lee et ai were included because data of 
the ineligible traumatic patient-groups could be 
separated from the data of the atraumatic part of 
the patient-population. Four studies4*‘492*33 de- 
scribed also patients who had experienced pre- 
operative seizures. Two of these, Franceschetti et 
al’” and Matthew et al’, could eventually be used 
because the patient-group with preoperative 
seizures could be separated from the patient- 
group without preoperative seizures. With the 
study of Sbeih et aP3 however, this was impos- 
sible, and for this reason the study was excluded. 
The results of the criteria based meta-analysis 
are shown in Table 2. 
Only half of the trials made an inventory of the 
side-effects of the administered AED-therapy. 
Usually, there are three different kinds of 
postoperative seizures defined, depending on the 
time of onset after the operation. The 
‘immediate-onset’ type occurs within 24 hours, 
the ‘early-onset’ within seven days and the 
‘late-onset’ in a period after one week. In three 
stUdies”,“4.“5 the follow-up took longer than one 
year. One studyI had a follow-up of minimal six 
months and two3*4 of one week or less (three 
days). In the studies of Lee et al3 and Matthew et 
al” the effectiveness of AEDs preventing post- 
operative convulsions of the ‘immediate-onset’ 
type was investigated. 
Scoring on different criteria was affected by a 
short follow-up, especially with the study of Lee 
et al-‘, favouring a good validity. 
In one caseI the baseline characteristics of the 
control and intervention-group were so sparsely 
described that less then the minimum score of 
three points was assigned. 
In two publications the data were presented in 
Foy+North+Lee 0.46 !  !  I.19 (P=O.l) 
0.74 : 
Foy+North 0.48 I * 
'0.7X : 
I.19 (P=O.l6) 
FOY 0.42 
I !  I .45 
'0.77 ; 
North 0.33 I : 1032; 
I .99 
Lee 0.06 I 2.41 
'0.42 
I I I I 
0.5 I .o I.5 2.0 2.5 
Odds ratio 
c--favours AED prophylaxis favours no AED prophylaxis--> 
Fig. 1: Odds ratios and confidence intervals (95%) of three statistical analyzed studies: Foy et a134, North et af’ and Lee ef a/3. 
If the confidence-interval (horizontal line), does not cross the vertical line (odds ratio is 1) then the difference in occurence of 
postoperative convulsions between prophylactic AEDs and placebo can be considered as statistical significant (P 5 0.025 
one-tailed). 
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Table 2: Results of the criteria based meta-analysis. Total score is presented as a percentage of the maximum of 145 points, 
indicating the methodological quality of the study 
Author Foy et al North er al Boarini er Franceschetti Leet er Matthew* 
(1992) (1983) al (1985) et al (1990) a/ (1989) et a/ (1980) 
Internal validity 
Comparability of prognosis 
Homogeneity (IO)* 
Prestratification (3) 
Randomization (10) 
Randomization procedure described (3) 
Comparability of relevant baseline 
characteristics shown (5) 
Patients per group (x): x 550.50 <x 5 100. 
x > 100 (3/5/7) 
Percentage of patients lost to follow-up: 
5 20% (4) 5 10% (7) 
Inrervention and external variables 
Plasma-levels of anti-epileptics adequate (15) 
Dose anti-epileptics adequate (3) 
Compliance (4) 
Intervention procedures adequately described 
(10) 
Effect measwemenr 
Patients blinded (10) 
Evaluator blinded (5) 
Check-up blinding (2) 
Proper and relevant outcome-measures 
Remark on side-effects (7) 
Remark on difference of seizure-frequency 
between groups (10) 
Remark on type of postoperative convulsions (5) 
Follow-up in months after treatment (3/7/9) 
Analysis 
Data presentation (5) 
Intention-to-treat analysis (5) 
Description of methods of analysis (5) 
Influence of confounding variables minimized 
(multi-variate analysis) (5) 
10 6 6 5 7 6 
3 3 -3 -3 3 -3 
10 10 0 10 10 0 
3 0 0 0 3 0 
5 5 5 3 5 0 
5 5 3 3 5 3 
0 0 0 
12 
3 
2 
10 
9 
3 
2 - 
10 
0 
0 
0 
7 
5 
0 
0 
0 
0 
0 
0 
0 
7 
5 
0 
0 
0 
0 
7 
10 
7 
10 
0 
10 
7 
10 
0 
10 
0 
10 
0 
9 
5 
9 
5 
7 
5 
7 
5 
3 
0 
3 
1 
0 
0 
Total score (percentage of max. 145) 76.6 87 37.2 44.8 72.4 15.9 
* Maximum scores are shown behind each methodological item 
t Follow-up is 3 days. 
$ Follow-up is 1 week. 
such a way that simple statistical calculations 
could be performed?. These two studies also 
used the intention-to-treat principle in contrast to 
the other studies. The most important 
characteristics of the various publications in- 
cluded in the meta-analysis are shown in Table 3. 
mentioned, the odds ratios and their 95% 
confidence intervals were calculated and pooled, 
using the Mantel-Haenszel Estimator”. 
On account of the fact that the trial of Lee et al3 
only had three follow-up days, and was therefore 
less comparable to the other two, the studies of 
North et al5 and Foy et a135 were also pooled 
without the study of Lee ef UP. 
The results are presented in Fig. 1. 
DISCUSSION 
In spite of an extensive literature search, only 30 
publications were found on the effectiveness of 
prophylactic AEDs. After exclusion of trials 
Statistical analysis 
The three studies selected (methodological qual- 
ity score ~55%) for further statistical analysis 
were: Foy et uL~~, North et al5 and Lee ef al”. In 
the trials of North and Lee, the trauma cupifis 
group could be separated and excluded from 
further statistical analysis. For the studies 
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Table 3: Most important characteristics of the six valid controlled studies included in the meta-analysis 
Foy CI ol (1992) North et al Boarini cf al Franceschetti er Lee ef a/ (1989) Matthew ef nl 
(1983) (1985) a/(1990) (1980) 
Trial-design Prospective Prospective Retrospective Prospective Prospective Retrospective 
Main pathology Aneurysm. Aneurysm, Supralentorial Supralentorial Various Various 
AVM, meningioma, astrocytomas neoplasms pathology pathology 
abscess. metastasis. 
spont. sellar tumor, 
haematoma. glioma. VA 
meningioma, shunt, other 
benign 
tumors 
Population size 276 181 68 63” 164< 
Score for 76.6 87 37.2 44.8 72.4 
methodology (% 
of 145) 
Antiepileptic Carbamazcpine Phenytoin Phenytoin or Phenobarbital Phenytoin 
prophylaxis or Phenytoin Phenobarbital or Phenytoin 
87” 
15.9 
or a 
combination 
ol both 
Period of 6 or 24 months 12 months 
prophylactic 
AED 
intervention 
Period of follow-up min. 3 years and 24 months 
max. 8 years 
Untraceable in 
publication 
Untraceable in 3 days 
publication 
Phenytoin or a 
combination of 
Phenytoin with 
Phenobarbital 
or 
Carbamazepine 
or Primidone 
Untraceable in 
publication 
Moment of max. 24 hours 
intervention before 
operation 
Statistical No 
significance of 
resull 
Author concludes No 
that prophylactic 
anti-epileptics 
are useful 
In the recovery- 
room 
Yes’ 
Yes 
min. 2 months 
and max. 52 
months 
max. 24 hours 
before 
operation 
No 
min. 6 months 3 days 
I week Shortly before 
preoperatively operation 
No No’ 
Yes’ ?’ 
I week 
Before operation 
No 
Yes’ 
(I) Only between day 7 and 72 and including a traumatic patient-population in the statistical analysis. (After leaving out the 
traumatic patients there was no statistical significant difference between intervention and control-group). 
(2) At prevention of Immediate/early-onset seizures but not of Late-onset seizures. 
(3) To the authors opinion more investigation is necessary. 
(4) After leaving out the traumatic patients there was no statistical significant difference between intervention and control-group. 
(5) After substraction of the head trauma population. 
(6) After substraction of the population of patients with preoperative seizures. 
published twice or more, review articles, trials 
without a control-group etc., only six clinical trials 
could be used for a meta-analysis. 
After a methodological scoring, three publica- 
tions remained with a sufficiently high methodol- 
ogical quality; the studies of Foy et LI~“~, North et 
afs and Lee et ni” with scores of respectively 
76.6%, 87% and 72.4%. 
Ultimately only one study remains, Foy et al-‘“, 
without traumatic patients and/or a too restricted 
follow-up period. These investigators conclude 
that AEDs should not be given prophylactically, 
because a statistically significant difference in 
outcome was not found. 
The effect of the intervention depends on the 
quality of the antiepileptic prophylaxis reached. 
An AED is supposed to work optimally if the 
plasma-levels are within the therapeutic range. 
Because of this the value of a conclusion about 
the effectiveness of the intervention is strongly 
associated with the criterion ‘Plasma-levels anti- 
epileptics adequate’. To define whether an 
epileptic seizure is the consequence of sub- 
therapeutic levels, and/or non-compliance, it is of 
great importance, especially with long term 
follow-up, to check plasma-levels regularly. This 
should be done both in the control- and 
intervention-group to guarantee patient-blinding. 
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In some of the studies4*‘4.34 it appears to be a 
serious problem to achieve therapeutic plasma- 
levels in patients. Most of the time it concerns the 
AED phenytoin which has complicated non- 
linear pharmacokinetics. Just in the first few days 
after a craniotomy prevention of postoperative 
seizures is very important because in this period 
most of the epileptic seizures (immediate onset- 
type) occur’7Q2”*2’, Generally it takes roughly five 
times the half-time of an AED to reach steady- 
state pharmacokinetics3’. With phenytoin (T* = 
14-31 hours3’“‘) it takes about one week. 
In future trials it might therefore be useful to 
start AEDs seven days before elective neurosur- 
gery in order to achieve adequate plasma-levels at 
the time of operation. In this way possible acute 
side-effects of the drug, which can appear during 
the loading-up period perioperative, can not 
complicate the postoperative condition of the 
patient. 
However, the amount of blood loss during the 
operation, which can be extensive with for 
example meningiomas, affects the postoperative 
AED-level and should be corrected for. 
Because the postoperative incidence of seizures 
differs quite a lot depending on the patients’ 
pathology2”*2’*24, prestratitication of the patient- 
population is very important. These differences in 
pathology complicate a meta-analysis by reducing 
the comparability of different studies. In this 
meta-analysis for example the trial of Boarini et 
aP4 and of Franceschetti er alI4 concern a specific 
pathology, namely gliomas. The incidence of 
postoperative seizures in patients with gliomas 
differs from that of patients with another intrac- 
ranial pathology2”*2’.24. Moreover, in glioma- 
patients it is difficult, certainly with longer 
follow-up periods, to differentiate between post- 
operative seizures caused by the surgical trauma 
or seizures caused by recurrence of the tumor. A 
reduction of the diversity of prognostic factors, 
especially the influence of the patients pathology, 
could be achieved by including only patients 
whose pathology gives rise to a high incidence of 
postoperative seizures5.2735. 
After calculation of the ORs of the studies of 
sufficient methodological quality (Foy, North, 
Lee), it could be determined that in none of these 
was a statistically significant effect achieved, 
although in all three studies a trend existed for 
AEDs to reduce the incidence of postoperative 
seizures (OR respectively: 0.77, 0.82, 0.42; see 
Fig. 1). The ORs of these three were subse- 
quently pooled using the Mantel-Haenszel Esti- 
mator, but even then statistical significance could 
not be reached. 
Even after pooling, the confidence intervals 
remained fairly wide. Therefore it is hard to say if 
the slight tendency of AEDs to prevent post- 
operative seizures, as deduced from statistical 
analysis, is of clinical importance. In the statistical 
analysis no distinction was made between im- 
mediate, early and late onset seizures because of 
the sparsity of data. In order to increase the 
power to detect a relevant treatment difference it 
is essential to enlarge the patient-population 
investigated. Narrowing of confidence intervals 
leading to a possible statistical significance can be 
obtained by a large multi-centre trial. Such a 
multi-centre trial has the advantage of quicker 
patient accrual, combined with reliable and more 
representative conclusions to be reached at a 
faster rate. Disadvantages are the organizational, 
logistic problems and high cost of large multi- 
centre trials. 
So the question can be raised whether the 
present prophylactic AED-use is that much 
harmful and disadvantageous to the patient, that 
empirical data, proving their effectiveness, must 
be obtained by means of a high cost and effort 
multi-centre trial. 
The decision to give prophylactic AEDs 
depends not only on its efficacy but also on factors 
such as adverse side-effects, discomfort to the 
patient and costs of the medication. In the 
publications studied here, only sparse attention 
was given to the latter factors. 
This is disappointing, given the fact that 
side-effects are often an important argument 
against the prophylactic use of AEDs. It seems 
that the conclusions in the studies concerning the 
use of AEDs were made solely on basis of 
trial-outcome determining drug efficacy. Espe- 
cially given the absence of statistical significance 
of the AED-prophylaxis in these studies, the 
importance of side-effects, discomfort to the 
patient and costs of medication beside thera- 
peutic efficacy, should be taken into account, and 
more carefully examined. Also the use of modern 
AEDs, with possibly fewer side-effects and 
shorter loading-up period, should be investigated 
in any new studies. 
Studying the effectiveness of AED- 
prophylaxis, the type and severity of convulsion 
should also be taken into account; part of the 
effectiveness of the AED-prophylaxis may en- 
compass a decrease in severity of a seizure. Of 
paramount importance in deciding on the use of 
prophylactic AEDs remains nevertheless . its 
clinical therapeutic effect. 
In conclusion, no empirical data supporting the 
attitude of using AEDs prophylactically with 
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supratentorial intracranial surgery, have been 
presented on a scientific basis. 
1989: 32: 389 (letter). 
17. 
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